The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

The notion that we should require placebo trials even when there's already a safe, effective vaccine goes against decades of ...

The MAHA commission's assessment of children's health mirrored RFK Jr.'s familiar targets. The question now is what remedies ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

A Merus drug, combined with Keytruda, shows preliminary survival gains in newly diagnosed metastatic head and neck cancer ...

His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech ...

WASHINGTON — The House passed President Trump’s tax-cutting plan early Thursday morning with the attendant health care ...

As Hinge Health goes public, CEO Dan Perez tells STAT the goal is to automate physical therapy in any way it can.

The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...

STAT reporters chat about the mood in the gene editing field, M&A deals in biotech, and leadership changes at Novo Nordisk.

The House Rules Committee passed the budget reconciliation bill late Wednesday night, teeing it up for House floor action.

In another sign of growing scrutiny over Covid-19 vaccines, the Food and Drug Administration has asked the two makers of mRNA ...